— Know what they know.
Not Investment Advice

GCAN OTC

Trafalgar International, Inc.
1W: +2.5% 1M: +8.7% 3M: +70.5% YTD: +65.1% 1Y: -28.0% 3Y: -78.4% 5Y: -96.1%
$1.60
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 61 · $318200 mcap · 197472 float · 0.648% daily turnover · Short 37% of daily vol

Balance Sheet Trends

Total Assets
$58K -66.5% ▼
5Y CAGR: +1.9%
Total Liabilities
$898K +7.7% ▲
5Y CAGR: -10.9%
Shareholders Equity
-$840K -27.1% ▼
Cash & Investments
$57K -65.6% ▼
5Y CAGR: +18.4%
Total Debt
$431K +0.0% ▲
5Y CAGR: -8.1%
Net Debt
$374K +41.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$113K$378K$270K$167K$57K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$113K$378K$270K$167K$57K
Net Receivables$37K$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$160K$378K$270K$167K$57K
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$20K$15K$10K$5K$417
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0-$0$0$0$0
Total Non-Current Assets$20K$15K$10K$5K$417
Total Assets$180K$393K$280K$172K$58K
— Liabilities —
Accounts Payable$7K$12K$16K$6K$8K
Short-Term Debt$283K$629K$503K$431K$431K
Deferred Revenue$153K$0$0$0$0
Other Current Liabilities$18K$18K$0$340K$0
Total Current Liabilities$460K$862K$825K$834K$898K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$520K$0$0
Total Liabilities$460K$862K$825K$834K$898K
— Equity —
Common Stock$465K$509K$733K$805K$805K
Retained Earnings-$3M-$4M-$4M-$4M-$5M
Accumulated OCI-$0$0$0$0$0
Total Stockholders Equity-$280K-$469K-$545K-$661K-$840K
Total Liabilities & Equity$180K$393K$280K$172K$58K
— Key Metrics —
Total Debt$283K$629K$503K$431K$431K
Net Debt$170K$252K$233K$265K$374K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms